More

    Europe Markets

    Telmisartan Actavis | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Telmisartan Actavis. It explains how the Committee for Medicinal Products for...

    Trajenta | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Trajenta. It explains how the Committee for Medicinal Products for Human...

    Zonisamide Viatris (previously Zonisamide Mylan)

    OverviewZonisamide Viatris is a medicine used to treat patients with partial seizures (epileptic fits starting in one part of the brain), including those...

    Olanzapine Viatris (previously Olanzapine Mylan)

    OverviewOlanzapine Viatris is used to treat adults with schizophrenia. Schizophrenia is a mental illness with symptoms such as delusions, disorganised thinking and speech, suspiciousness and...

    Cinacalcet Viatris (previously Cinacalcet Mylan)

    OverviewCinacalcet Viatris is a medicine used to:treat secondary hyperparathyroidism (overactive parathyroid glands) in adults with serious kidney disease who need dialysis (to clear...

    Ozempic | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Ozempic. It explains how the Agency assessed the medicine to recommend...

    M-RVaxPro | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for M-M-RVaxPro. It explains how the Agency assessed the medicine to recommend...

    Amvuttra | European Medicines Agency (EMA)

    OverviewAmvuttra is a medicine used to treat polyneuropathy (nerve damage) caused by hereditary transthyretin-mediated (hATTR) amyloidosis, a disease in which abnormal proteins called...

    Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Efavirenz/Emtricitabine/Tenofovir disoproxil Krka. It explains how the Agency assessed the medicine...

    Fetcroja | European Medicines Agency (EMA)

    OverviewFetcroja is an antibiotic used in adults to treat infections caused by bacteria classed as aerobic Gram-negative bacteria. It is for use when...

    Levodopa/Carbidopa/Entacapone Orion | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Levodopa/Carbidopa/Entacapone Orion. It explains how the Committee for Medicinal Products for...

    Lytenava | European Medicines Agency (EMA)

    OverviewLytenava is a medicine used to treat adults with the ‘wet’ form of age-related macular degeneration (AMD), a disease that affects the central...

    Tyruko | European Medicines Agency (EMA)

    OverviewTyruko is a medicine used in adults to treat highly active multiple sclerosis (MS) that is rapidly getting worse or that is not...

    Imvanex | European Medicines Agency (EMA)

    OverviewImvanex is a vaccine used to protect against smallpox in adults and adolescents aged 12 years and older.Smallpox was officially declared eradicated in...

    Tadalafil Mylan | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Tadalafil Mylan. It explains how the Agency assessed the medicine to...

    Paxlovid | European Medicines Agency (EMA)

    OverviewPaxlovid is a medicine used for treating COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of...